Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03681678 · ClinicalTrials.gov registry record
Laser Therapy for Treatment of Urogenital Symptoms in Women
A clinical trial, sponsored by Corewell Health East.
- Completed
- Registry status
- 100
- Enrollment target
NCT03681678: Completed study, sponsored by Corewell Health East.
NCT03681678 is a clinical trial that has completed, run by Corewell Health East. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03681678 has completed, sponsored by Corewell Health East.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
This is a prospective observational study of women undergoing vaginal treatment with the fractional carbon dioxide (fCO2) laser for various urogenital symptoms.
Primary Outcome
PGI-I score is recorded 4 weeks after initial treatment completion. The PGI-I asks the patient to "check the box that best describes how your urinary and/or vaginal symptoms are now, compared with how you symptoms were before you began this study." There are 7 possible responses ranging from 1 to 7, where 1 is "Very Much Better", 2 is "Much Better, 3 is "A Little Bit Better", 4 is "No Change", 5 is "A Little Worse", 6 is "Much Worse", and 7 is "Very Much Worse". A score from 1 to 3 would indicat
Interventions
- DEVICE fCO2 Laser Therapy Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2018-10-08 |
| Est. Completion | 2025-06-10 |
What the finished NCT03681678 record still lists
NCT03681678 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which fCO2 Laser Therapy Group is the first listed.
NCT03681678 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03681678 about?
NCT03681678 is a clinical study titled "Laser Therapy for Treatment of Urogenital Symptoms in Women". This is a prospective observational study of women undergoing vaginal treatment with the fractional carbon dioxide (fCO2) laser for various urogenital symptoms.
What is the current status of trial NCT03681678?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2018-10-08. Estimated completion is 2025-06-10.
What interventions are being tested in trial NCT03681678?
The interventions under investigation include: fCO2 Laser Therapy Group (DEVICE).
Who is sponsoring clinical trial NCT03681678?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI